These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38549761)

  • 41. Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes.
    Darvishi P; Batchala PP; Patrie JT; Poisson LM; Lopes MB; Jain R; Fadul CE; Schiff D; Patel SH
    AJNR Am J Neuroradiol; 2020 May; 41(5):815-821. PubMed ID: 32327434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Return to Work Following Surgery for Incidental Diffuse Low-Grade Glioma: A Prospective Series With 74 Patients.
    Ng S; Herbet G; Moritz-Gasser S; Duffau H
    Neurosurgery; 2020 Sep; 87(4):720-729. PubMed ID: 31813972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas.
    Powell RT; Olar A; Narang S; Rao G; Sulman E; Fuller GN; Rao A
    J Pathol Inform; 2017; 8():9. PubMed ID: 28382223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature.
    Chaichana KL; McGirt MJ; Niranjan A; Olivi A; Burger PC; Quinones-Hinojosa A
    Neurol Res; 2009 Nov; 31(9):931-9. PubMed ID: 19215664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute progression of untreated incidental WHO Grade II glioma to glioblastoma in an asymptomatic patient.
    Cochereau J; Herbet G; Rigau V; Duffau H
    J Neurosurg; 2016 Jan; 124(1):141-5. PubMed ID: 26162036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype.
    Patel SH; Bansal AG; Young EB; Batchala PP; Patrie JT; Lopes MB; Jain R; Fadul CE; Schiff D
    AJNR Am J Neuroradiol; 2019 Jul; 40(7):1149-1155. PubMed ID: 31248860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.
    Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G
    Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter study.
    Ius T; Ng S; Young JS; Tomasino B; Polano M; Ben-Israel D; Kelly JJP; Skrap M; Duffau H; Berger MS
    Neuro Oncol; 2022 Apr; 24(4):624-638. PubMed ID: 34498069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016.
    Compes P; Tabouret E; Etcheverry A; Colin C; Appay R; Cordier N; Mosser J; Chinot O; Delingette H; Girard N; Dufour H; Metellus P; Figarella-Branger D
    J Neurooncol; 2019 May; 142(3):511-520. PubMed ID: 30756272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
    Liu L; Yang Y; Duan H; He J; Sun L; Hu W; Zeng J
    Front Oncol; 2021; 11():611038. PubMed ID: 33937022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
    Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
    J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiating Nonenhancing Grade II Gliomas from Grade III Gliomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.
    Alkanhal H; Das K; Rathi N; Syed K; Poptani H
    World Neurosurg; 2021 Feb; 146():e555-e564. PubMed ID: 33152494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas.
    Pyka T; Gempt J; Hiob D; Ringel F; Schlegel J; Bette S; Wester HJ; Meyer B; Förster S
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):133-141. PubMed ID: 26219871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multimodal Assessment Shows a Mostly Preserved Cognitive Status in Incidentally Discovered Low Grade Gliomas: A Single Institution Study.
    Guarracino I; Ius T; Pegolo E; Cesselli D; Skrap M; Tomasino B
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
    Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Reappraisal of the Sainte-Anne Hospital classification of oligodendrogliomas in view of retrospective studies].
    Daumas-Duport C; Koziak M; Miquel C; Nataf F; Jouvet A; Varlet P
    Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):247-53. PubMed ID: 16292168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes.
    Chen J; Wu L; Yang H; Zhang X; Xv S; Qian Q
    Front Immunol; 2022; 13():982033. PubMed ID: 36052073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A survival analysis of surgically treated incidental low-grade glioma patients.
    Zeng L; Mei Q; Li H; Ke C; Yu J; Chen J
    Sci Rep; 2021 Apr; 11(1):8522. PubMed ID: 33875775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Voxel-based clustered imaging by multiparameter diffusion tensor images for glioma grading.
    Inano R; Oishi N; Kunieda T; Arakawa Y; Yamao Y; Shibata S; Kikuchi T; Fukuyama H; Miyamoto S
    Neuroimage Clin; 2014; 5():396-407. PubMed ID: 25180159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    Fouke SJ; Benzinger T; Gibson D; Ryken TC; Kalkanis SN; Olson JJ
    J Neurooncol; 2015 Dec; 125(3):457-79. PubMed ID: 26530262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.